Overview
HNGE market data
Price History
HNGE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$9.68 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.00 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $30.08 – $62.18 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $4.2K · P/B 9.66 · P/S 7.09.
Company news
Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $100Benzinga · Jul 21, 2026, 11:29 AM
Barclays Maintains Overweight on Hinge Health, Raises Price Target to $97Benzinga · Jul 13, 2026, 12:35 PM
Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $125Benzinga · Jul 13, 2026, 12:24 PM
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $108Benzinga · Jul 13, 2026, 11:06 AM
Digital Health for the Musculoskeletal Care Market: 2026-2032 Outlook | Increasing Investment in Health and Fitness Apps Drives Adoption of Digital Health Solutions for Musculoskeletal Health TrackingGlobenewswire Inc · Jun 24, 2026, 2:15 PM
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $90Benzinga · Jun 24, 2026, 1:55 PM
Baird Maintains Neutral on Hinge Health, Raises Price Target to $65Benzinga · Jun 17, 2026, 11:35 AM
Raymond James Maintains Outperform on Hinge Health, Raises Price Target to $80Benzinga · Jun 15, 2026, 6:00 PM
Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $76Benzinga · Jun 15, 2026, 3:40 PM
Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $90Benzinga · Jun 12, 2026, 1:10 PM